Market Overview:
The global soft tissue reinforcement and regeneration market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of sports injuries, rising awareness about regenerative medicine, and technological advancements in soft tissue reinforcement and regeneration products. The global soft tissue reinforcement and regeneration market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into allografts, xenografts, alloplastics, synthetic biologics, and others. On the basis of application, the market is segmented into dental tissue regeneration,, vaginal sling,, hernia repair,, breast reconstruction,, sport medicine & tendon reinforcement,, dural repair,.and others. The North American region dominates this market followed by Europe due to early adoption rates for new technologies in these regions.
Product Definition:
Soft tissue reinforcement and regeneration is the process of repairing or replacing soft tissues, such as muscles, tendons, ligaments, and nerves. This can be done through surgery or with the help of medical devices or therapies. The goal of soft tissue reinforcement and regeneration is to improve the function and strength of these tissues, as well as to reduce pain and inflammation.
Allograft:
Allografts are synthetic materials that are used to replace or regenerate the function of a damaged or diseased organ. The most common allograft used for soft tissue reconstruction is human skin, which is derived from cadaveric human skin. Other types of allografts include dermis, tendons, and bone.
Xenograft:
Xenografts are also known as allografts or artificial organs. They are tissue-based reconstructions that come from an animal source such as porcine, bovine, avian (bird), and equine.
Application Insights:
The dental tissue regeneration segment held the largest market share in 2017 and is anticipated to continue its dominance over the forecast period. This can be attributed to increasing awareness about oral hygiene and rising incidences of tooth decay and gum diseases, which are majorly seen in developing countries like India, China, etc. As per a study published by National Center for Biotechnology Information (NCBI) in 2018, around 60% of adults suffer from some form of tooth decay while 30% have some form of periodontal disease. The aforementioned factors are expected to boost demand for soft tissue reconstruction procedures during dental surgeries leading to an increase in revenue generation capacity for regenerative medicine across various healthcare facilities during surgery.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high disposable income, and increasing awareness about available treatments. Moreover, government support for R&D activities pertaining to soft tissue healing is expected to fuel regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising medical tourism and improving healthcare facilities in emerging economies such as India and China. In addition, growing investments by international companies for expanding their business operations in this region are expected favorably impact regional demand during the same period. ‰â€˜”‘”‘¬'s Soft Tissue Repair System (STRS) was launched across North America with a strong focus on gaining approval from FDA for marketing STRS products within U.S.
Growth Factors:
- Increasing incidence of sports injuries and accidental injuries
- Growing awareness about the benefits of soft tissue reinforcement and regeneration therapies
- Rising demand for minimally invasive procedures
- Technological advancements in soft tissue reinforcement and regeneration therapies
- increasing prevalence of chronic diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Soft Tissue Reinforcement and Regeneration Market Research Report
By Type
Allograft, Xenograft, Alloplast, Synthetic, Biologic, Others
By Application
Dental Tissue Regeneration, Vaginal Sling, Hernia Repair, Breast Reconstruction, Sport Medicine and Tendon Reinforcement, Dural Repair, Others
By Companies
BioHorizons, Biomet, Geistlich, Smith & Nephew, RTI Biologics, MiMedx, LifeCell, Atrium Medical, Zimmer Holdings, Cook Medical, Dentsply, Medtronic, Stryker, Ethicon, Boston Scientific, American Medical Systems, Integra LifeSciences and Citagenix
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Soft Tissue Reinforcement and Regeneration Market Report Segments:
The global Soft Tissue Reinforcement and Regeneration market is segmented on the basis of:
Types
Allograft, Xenograft, Alloplast, Synthetic, Biologic, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dental Tissue Regeneration, Vaginal Sling, Hernia Repair, Breast Reconstruction, Sport Medicine and Tendon Reinforcement, Dural Repair, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioHorizons
- Biomet
- Geistlich
- Smith & Nephew
- RTI Biologics
- MiMedx
- LifeCell
- Atrium Medical
- Zimmer Holdings
- Cook Medical
- Dentsply
- Medtronic
- Stryker
- Ethicon
- Boston Scientific
- American Medical Systems
- Integra LifeSciences and Citagenix
Highlights of The Soft Tissue Reinforcement and Regeneration Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Allograft
- Xenograft
- Alloplast
- Synthetic
- Biologic
- Others
- By Application:
- Dental Tissue Regeneration
- Vaginal Sling
- Hernia Repair
- Breast Reconstruction
- Sport Medicine and Tendon Reinforcement
- Dural Repair
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Soft Tissue Reinforcement and Regeneration Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Soft tissue reinforcement and regeneration is the process of repairing or replacing damaged or lost soft tissues. This can be done through a variety of methods, including surgery, injections, and implants. Soft tissue reconstruction can help restore function to areas that have been damaged by injury or disease.
Some of the major companies in the soft tissue reinforcement and regeneration market are BioHorizons, Biomet, Geistlich, Smith & Nephew, RTI Biologics, MiMedx, LifeCell, Atrium Medical, Zimmer Holdings, Cook Medical, Dentsply, Medtronic, Stryker, Ethicon, Boston Scientific, American Medical Systems, Integra LifeSciences and Citagenix.
The soft tissue reinforcement and regeneration market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Soft Tissue Reinforcement and Regeneration Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Soft Tissue Reinforcement and Regeneration Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Soft Tissue Reinforcement and Regeneration Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Soft Tissue Reinforcement and Regeneration Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Soft Tissue Reinforcement and Regeneration Market Size & Forecast, 2020-2028
4.5.1 Soft Tissue Reinforcement and Regeneration Market Size and Y-o-Y Growth
4.5.2 Soft Tissue Reinforcement and Regeneration Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Allograft
5.2.2 Xenograft
5.2.3 Alloplast
5.2.4 Synthetic
5.2.5 Biologic
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Dental Tissue Regeneration
6.2.2 Vaginal Sling
6.2.3 Hernia Repair
6.2.4 Breast Reconstruction
6.2.5 Sport Medicine and Tendon Reinforcement
6.2.6 Dural Repair
6.2.7 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Soft Tissue Reinforcement and Regeneration Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Soft Tissue Reinforcement and Regeneration Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Allograft
9.6.2 Xenograft
9.6.3 Alloplast
9.6.4 Synthetic
9.6.5 Biologic
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Dental Tissue Regeneration
9.10.2 Vaginal Sling
9.10.3 Hernia Repair
9.10.4 Breast Reconstruction
9.10.5 Sport Medicine and Tendon Reinforcement
9.10.6 Dural Repair
9.10.7 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Allograft
10.6.2 Xenograft
10.6.3 Alloplast
10.6.4 Synthetic
10.6.5 Biologic
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Dental Tissue Regeneration
10.10.2 Vaginal Sling
10.10.3 Hernia Repair
10.10.4 Breast Reconstruction
10.10.5 Sport Medicine and Tendon Reinforcement
10.10.6 Dural Repair
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Allograft
11.6.2 Xenograft
11.6.3 Alloplast
11.6.4 Synthetic
11.6.5 Biologic
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Dental Tissue Regeneration
11.10.2 Vaginal Sling
11.10.3 Hernia Repair
11.10.4 Breast Reconstruction
11.10.5 Sport Medicine and Tendon Reinforcement
11.10.6 Dural Repair
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Allograft
12.6.2 Xenograft
12.6.3 Alloplast
12.6.4 Synthetic
12.6.5 Biologic
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Dental Tissue Regeneration
12.10.2 Vaginal Sling
12.10.3 Hernia Repair
12.10.4 Breast Reconstruction
12.10.5 Sport Medicine and Tendon Reinforcement
12.10.6 Dural Repair
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Allograft
13.6.2 Xenograft
13.6.3 Alloplast
13.6.4 Synthetic
13.6.5 Biologic
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Dental Tissue Regeneration
13.10.2 Vaginal Sling
13.10.3 Hernia Repair
13.10.4 Breast Reconstruction
13.10.5 Sport Medicine and Tendon Reinforcement
13.10.6 Dural Repair
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Soft Tissue Reinforcement and Regeneration Market: Competitive Dashboard
14.2 Global Soft Tissue Reinforcement and Regeneration Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BioHorizons
14.3.2 Biomet
14.3.3 Geistlich
14.3.4 Smith & Nephew
14.3.5 RTI Biologics
14.3.6 MiMedx
14.3.7 LifeCell
14.3.8 Atrium Medical
14.3.9 Zimmer Holdings
14.3.10 Cook Medical
14.3.11 Dentsply
14.3.12 Medtronic
14.3.13 Stryker
14.3.14 Ethicon
14.3.15 Boston Scientific
14.3.16 American Medical Systems
14.3.17 Integra LifeSciences and Citagenix
